FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 79 filers reported holding FATE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $16,000 | +33.3% | 800 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | -25.0% | 800 | 0.0% | 0.00% | – |
Q2 2019 | $16,000 | -15.8% | 800 | -27.3% | 0.00% | – |
Q1 2019 | $19,000 | +35.7% | 1,100 | 0.0% | 0.00% | – |
Q4 2018 | $14,000 | -41.7% | 1,100 | -27.4% | 0.00% | – |
Q3 2018 | $24,000 | +33.3% | 1,515 | -5.3% | 0.00% | – |
Q2 2018 | $18,000 | +12.5% | 1,600 | 0.0% | 0.00% | – |
Q1 2018 | $16,000 | +14.3% | 1,600 | -30.4% | 0.00% | – |
Q4 2017 | $14,000 | +55.6% | 2,300 | 0.0% | 0.00% | – |
Q3 2017 | $9,000 | +12.5% | 2,300 | -11.5% | 0.00% | – |
Q2 2017 | $8,000 | -11.1% | 2,600 | +30.0% | 0.00% | – |
Q1 2017 | $9,000 | +80.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |